Načítá se...
Angiotensin receptor blockers and COVID-19
Angiotensin Receptor Blockers (ARBs) exhibit major pleiotropic protecting effects beyond their antihypertensive properties, including reduction of inflammation. ARBs directly protect the lung from the severe acute respiratory syndrome as a result of viral infections, including those from coronavirus...
Uloženo v:
| Vydáno v: | Pharmacol Res |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier Ltd.
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7158830/ https://ncbi.nlm.nih.gov/pubmed/32304747 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.phrs.2020.104832 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|